ArcScan

About ArcScan

ArcScan, founded in 2007 by John Watson, is a medical device company specializing in advanced ophthalmic imaging technology. The company develops and markets high-resolution, robotic ultrasound scanners that provide detailed, micron-resolution images of the anterior segment of the eye. This technology assists ophthalmologists in the diagnosis and treatment of various eye conditions, and in the planning and execution of refractive, corneal, cataract, and glaucoma surgeries.

The company's flagship product, the ArcScan Insight® 100, is designed to provide precise measurements and imaging of the eye, helping to improve surgical outcomes for patients. The device's ability to see through the wall of the eye and behind the iris offers a significant advantage over other imaging technologies.

ArcScan operates in the ophthalmic medical device market, serving a client base of ophthalmologists, eye clinics, and hospitals. The company's business model is based on the sale of its imaging devices and related services. Andrew K. Levien currently leads the company as CEO.

Over the years, ArcScan has secured funding from investors such as Shanghai Hao Hai Healthcare and the Kevin M. McGovern Family Center for Venture Development in the Life Sciences, enabling it to further develop and commercialize its technology.